| Database ID | Agent | Target | Cancer Type | Detail |
| DB00691 | ganitumab | Insulinlike growth factor I receptor | advanced solid tumors | view |
| DB00692 | PF00562271 | Focal adhesion kinase | advanced solid tumors | view |
| DB00693 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | advanced solid tumors | view |
| DB00694 | cediranib and saracatinib | cediranib: Vascular endothelial growth factor receptor 2
saracatinib: Protooncogene tyrosineprotein kinase SRC
Abl | advanced solid tumors | view |
| DB00695 | bavituximab | membrane phospholipid phosphatidylserine (PS) | advanced solid tumors | view |
| DB00696 | PF03814735 | Serine/threonine protein kinase 12
Aurora kinase A | advanced solid tumors | view |
| DB00697 | SU014813 | VEGFR2, PDGFR¦Â and FLT3ITD phosphorylation | advanced solid tumors | view |
| DB00698 | JNJ26483327 | Epidermal growth factor receptor
Protooncogene tyrosineprotein kinase Fyn
Lyn tyrosine kinase
Receptor proteintyrosine kinase erbB2
Vascular endothelial growth factor receptor 3
Protooncogene tyrosineprotein kinase LCK
Protooncogene tyrosineprotein kinase Yes
Receptor proteintyrosine kinase erbB4 | advanced solid tumors | view |
| DB00699 | YM155 | NA | advanced solid tumors | view |
| DB00700 | ZK 304709 | Cell division protein kinase 4
Cell division control protein 2 homolog
Cell division protein kinase 9
Cell division protein kinase 7
Cell division protein kinase 2 | advanced solid tumors | view |
| DB00701 | sorafenib and bevacizumab | NA | advanced solid tumors | view |
| DB00702 | ZK 304709 | Cell division protein kinase 4
Cell division control protein 2 homolog
Cell division protein kinase 9
Cell division protein kinase 7
Cell division protein kinase 2 | advanced solid tumors | view |
| DB00703 | pertuzumab | Receptor proteintyrosine kinase erbB2 | advanced solid tumors | view |
| DB00704 | sorafenib and erlotinib | NA | advanced solid tumors | view |
| DB00705 | SU5416 | Vascular endothelial growth factor | advanced solid tumors | view |